Table of Contents
Why Laurus Labs is down?
(₹ Cr.) Face value of a stock is the value ascribed to the stock as per the balance sheet of the company….Key Metrics.
1 Month | 1.03 |
---|---|
6 Months | 0.79 |
1 Year | 0.73 |
3 Years | – |
When Laurus Labs split shares will be credited?
Laurus Labs Ltd.
Announcement Date | Old FV | Ex-Split Date |
---|---|---|
30-04-2020 | 10 | 29-09-2020 |
What Laurus Labs do?
Laurus Labs is a leading research and development (‘R&D’) driven pharmaceutical company in India with a leadership position in generic active pharmaceutical ingredients (‘APIs’) for select high-growth therapeutic areas of anti-retrovirals (‘ARVs’) Hepatitis C and Oncology.
Is morepen Labs a good buy Quora?
The company is almost debt-free. The company has delivered good profit growth of 18.65\% CAGR over the last 5 years. The company has a good return on equity (ROE) track record: 3 Years ROE 68.06\%.
Is Laurus Labs a good buy for long term?
Is Laurus Labs a good long term investment? Past 10 years financial track record analysis and assessment of future prospects by Moneyworks4me indicates that Laurus Labs Ltd is a good long term investment. However, you need to ensure you buy at a right price to earn good returns.
Is Laurus lab giving bonus?
Laurus Labs has not announced any bonus so far.
Is Laurus Labs a good company?
Good work environment and culture. Teammates are supportive and the management is transparent. Company policies are good, appraisals are fair and they give good salary hike and bonus every year.
Is morepen lab multibagger?
Pharma smallcap Morepen Laboratories has been thumping rock and roll over the past few weeks; it delivered multibagger returns for last financial year, and has already delivered over 125 per cent return for this financial year so far, up from Rs 32 on April 1.
Sharekhan is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 800 in its research report dated September 28, 2021.
https://www.youtube.com/watch?v=yIxWbJ2AS2o